Arene Life Sciences is an API manufacturer based in India. It holds 31 active US drug master files across a filed portfolio of 16 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 30 August 2024 as VAI. Customs aggregates show $7.0M of exports covering 140 molecules to 29 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Nalgonda, India | 3033870708 |
| Sangareddy, India | 3013438177 |
| Molecule | Regulators | Docs |
|---|---|---|
| Dolutegravir | SFDA (Saudi Arabia), US FDA | 3 |
| Amlodipine | US FDA | 2 |
| Bictegravir | US FDA | 2 |
| Clopidogrel | US FDA | 2 |
| Darunavir | US FDA | 2 |
| Efavirenz | US FDA | 2 |
| Emtricitabine | US FDA | 2 |
| Lamivudine | US FDA | 2 |
| Lopinavir | US FDA | 2 |
| Nefopam | US FDA | 2 |
| Oxcarbazepine | US FDA | 2 |
| Ritonavir | US FDA | 2 |
| Tedizolid | US FDA | 2 |
| Tenofovir Alafenamide | US FDA | 2 |
| Trazodone | US FDA | 2 |
| Eslicarbazepine Acetate | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $4.3M | 17 |
| 2025 | Not reported | $7.0M | 29 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Arene Life Sciences comes back tiered against every other supplier able to file there.
Start for free